Skip to main content
Log in

A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Baseline and sequential liver biopsies were performed in ten patients with rheumatoid arthritis (RA) treated with methotrexate (MTX) for more than 4 years. Liver biopsies were performed in all patients before the initiation of MTX therapy and were repeated after reaching a cumulative dose of 1500 mg or more. In four patients a third biopsy was performed 3 years after the first one. No significant worsening of hepatic architecture was found in any of our patients after 4 to 71/2 years of MTX therapy. No correlations between histologic findings and various clinical or pharmacological variables could be found. Our results suggested that prolonged MTX administration in RA patients did not cause severe hepatic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Weinblatt ME, Coblyn JS, Fraser PA, Holdsworth DE, Falchuk KR, Trentham DE (1988) Long term prospective study of methotrexate in rheumatoid arthritis. Arthritis Rheum 31:167–175

    Google Scholar 

  2. Kremer JM, Lee JK (1988) A long term prospective study of methotrexate in rheumatoid arthritis: An update after a mean of 53 months. Arthritis Rheum 31:577–584

    Google Scholar 

  3. Tishler M, Caspi D, Rosenbach TO, Fishel B, Wigler I, Gazit E, Yaron M (1988) Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations. Ann Rheum Dis 47:654–659

    Google Scholar 

  4. Gispen JG, Alarcon GS, Johnson JJ, Acton RT, Barger BO, Koopman WJ (1987) Toxicity to methotrexate in rheumatoid arthritis. J Rheumatol 14:74–79

    Google Scholar 

  5. Nyfors A, Poulson H (1976) Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotrexate therapy in 88 patients: a blind study. Acta Pathol Microbiol Scand 84:262–270

    Google Scholar 

  6. Lefkowitz AM, Farrow IJ (1955) The liver in rheumatoid arthritis. 15 years experience. Am J Med 75:69–73

    Google Scholar 

  7. Hoffmeister RT (1983) Methotrexate therapy in rheumatoid arthritis. 15 years experience. Am J Med 75:69–73

    Google Scholar 

  8. Kremer JM, Lee RG, Tolman KG (1989) Liver histology in rheumatoid arthritis patients receiving long term methotrexate therapy. Arthritis Rheum 32:121–127

    Google Scholar 

  9. Brick JE, Moreland LW, Al-Kawas F, Chang W, Layne RD, DiBartolomeo AG (1989) Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid arthritis. Semin Arthritis Rheum 19:31–44

    Google Scholar 

  10. Loo AP, MacKenzie AH, Tutrill RJ, Leatherman JR (1985) Liver histology in rheumatoid arthritis before and after prolonged methotrexate therapy. Arthritis Rheum 28:S14

  11. Roenigh HH, Auerbach R, Marbach AI, Weinstein GD (1982) Methotrexate guidelines: revised. J Am Acad Dermatol 6:145–155

    Google Scholar 

  12. Colsky J, Greenspan EM, Warren TN (1955) Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists. Arch Pathol Lab Med 59:198–206

    Google Scholar 

  13. Roenigk HH, Bergfeld WF, St Jaques R, Owens FJ, Hawk WA (1971) Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol 103:250–261

    Google Scholar 

  14. Aponte J, Petrelli M (1988) Histopathologic findings in the liver of rheumatoid arthritis patients treated with long term bolus methotrexate. Arthritis Rheum 31:1457–1464

    Google Scholar 

  15. Mackenzie AH (1985) Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis. Clev Clin Q 52:129–135

    Google Scholar 

  16. Hoyumpa AM, Greene HL, Dunn GD, Schenker S (1975) Fatty liver: biochemical and clinical characteristics. Am J Dig Dis 20:1142–1170

    Google Scholar 

  17. Bridges SL, Alarcon GS, Koopman WJ (1989) Editorial: Methotrexate induced liver abnormalities in rheumatoid arthritis. J Rheumataol 16:1180–1182

    Google Scholar 

  18. Willkens RF, Leonard PA, Clegg DO, Tolman KG, Ward JR, Marks CR, Greene ML, Roth GH, Jackson CG, Cannon GW, Lee RG (1990) Liver histology in patients receiving low dose pulse methotrexate for the treatment of arthritis. Ann Rheum Dis 49:591–593

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tishler, M., Caspi, D., Halperin, Z. et al. A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy. Rheumatol Int 12, 39–41 (1992). https://doi.org/10.1007/BF00246875

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00246875

Key words

Navigation